Newly on Gate2Biotech

Veterinary Market – How Innovative?

29.11.2012   |   Newly on Gate2Biotech

European veterinary market of new medicinal products noted a dynamic growth over the past 20 years. EU regulations - numerous at that period of time - were smoothly implemented. But what is more significant – veterinary market efficiently resisted the economic slowdown. It is important to mark that such a good condition of the branch is a result...

Continue


Getting together at PHARM Connect 2013!
Credit: FotolEdhar - Fotolia.com

Getting together at PHARM Connect 2013!

26.11.2012   |   Newly on Gate2Biotech

Biotech and Pharma professionals getting together to overcome industry-specific challenges and develop genuine partnerships at PHARM Connect. In the aftermath of the global recession, the pharmaceutical and biotechnology industry has been facing new challenges.

Continue


Direvo introduces BluCon™ for the conversion of non-food biomass to biofuel and chemical building blocks
Credit: luchshen - Fotolia.com

Direvo introduces BluCon™ for the conversion of non-food biomass to biofuel and chemical building blocks

15.11.2012   |   Newly on Gate2Biotech

Cologne, Germany, November 12, 2012. Direvo Industrial Biotechnology GmbH is commercializing its BluConTM platform for complete, one-step conversion of non-food feedstocks to carbohydrates used in the production of fuels and chemicals. In the recent years Direvo has undertaken a huge research program identifying a portfolio of proprietary...

Continue


Nimbus discovery and Proteros enter into privileged X-RAY crystallography partnership agreement
Credit: FotolEdhar - Fotolia.com

Nimbus discovery and Proteros enter into privileged X-RAY crystallography partnership agreement

13.11.2012   |   Newly on Gate2Biotech

Martinsried, Germany, November 12, 2012. Proteros biostructures GmbH ("Proteros") today announced that it has executed a Privileged Partnership Agreement with Nimbus Discovery LLC (Nimbus), Cambridge, Massachusetts, USA.

Continue


The Top CEE biotech licensing opportunities

29.10.2012   |   Newly on Gate2Biotech

Pharmaceutical companies are looking for sources of new products and technologies in biotechnology industry to extend the existing pipeline. The major objectives of pharmaceutical and biotechnology businesses are to be the first on the market with new therapeutic entities, achieve maximum market penetration, be assured of freedom to operate, and...

Continue


BioForum opens for the veterinary market!

17.10.2012   |   Newly on Gate2Biotech

The innovative bib-business is a main – apart from the IT – driving force of the modern economy. Therefore, every year since 2000 we organize BioForum – the event that meets the needs of the emerging Central European biotech companies and creates the optimal conditions for their development.

Continue


New innovative enzyme technologies improving economics for the ethanol and livestock feeding industries

15.10.2012   |   Newly on Gate2Biotech

Cologne, Germany, October 8, 2012: Direvo Industrial Biotechnology GmbH is introducing its BluZy™-product development platform, delivering innovative biology-based solutions to improve economics of renewable fuels and livestock feeding markets. Direvo´s most advanced product, BluZy™-D, substantially improves the nutritional value of DDGS and...

Continue


Hungarian Biotechnology Association - the main partner of Bioforum 2013
Credit: FotolEdhar - Fotolia.com

Hungarian Biotechnology Association - the main partner of Bioforum 2013

8.10.2012   |   Newly on Gate2Biotech

Quite recently, Central European region has regained freedom and undergone deep structural and social changes. Our common objective is to converge with the Western world’s development in terms of technology, bioeconomy and the standard of living.

Continue


UCB and Proteros expand successful protein x-ray crystallography collaboration
Credit: CONTIPRO

UCB and Proteros expand successful protein x-ray crystallography collaboration

18.9.2012   |   Newly on Gate2Biotech

Collaboration aims to accelerate drug discovery for new therapies in central nervous system (CNS) disorders and immunology diseases.

Continue


Sophion announces the Qube - the next generation platform for ion channel screening

6.9.2012   |   Newly on Gate2Biotech

Ballerup, Denmark (September 4, 2012). Sophion Bioscience announces the upcoming release of the latest state-of-the-art instrument for automated patch clamp, the Qube.

Continue


Page: Previous   10 11 12 13 14 15 16 17 18 19 20 21 22 23   Next

 

OPPI, MPO, EU

CEBIO

  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina
  • ALIDEA

LinkedIn
TOPlist